Your browser doesn't support javascript.
loading
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
Baird, Kristin; Comis, Leora E; Joe, Galen O; Steinberg, Seth M; Hakim, Fran T; Rose, Jeremy J; Mitchell, Sandra A; Pavletic, Steven Z; Figg, William D; Yao, Lawrence; Flanders, Kathleen C; Takebe, Naoko; Sarantopoulos, Stefanie; Booher, Susan; Cowen, Edward W.
Afiliación
  • Baird K; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Comis LE; Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Joe GO; Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Hakim FT; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Rose JJ; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Mitchell SA; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland.
  • Pavletic SZ; Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Figg WD; Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Yao L; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Flanders KC; Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Takebe N; Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Sarantopoulos S; Division of Hematologic Malignancy and Cell Therapy and Duke Cancer Institute, Department of Medicine, Duke University, Durham, North Carolina.
  • Booher S; Autoimmunity and Mucosal Immunology Branch, National Institute of Allergy and Infectious Diseases, Rockville, Maryland.
  • Cowen EW; Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: edcowen@hotmail.com.
Biol Blood Marrow Transplant ; 21(6): 1083-90, 2015 Jun.
Article en En | MEDLINE | ID: mdl-25771402
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Leucemia / Trasplante de Células Madre Hematopoyéticas / Fascitis / Mesilato de Imatinib / Enfermedad Injerto contra Huésped / Antineoplásicos Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Leucemia / Trasplante de Células Madre Hematopoyéticas / Fascitis / Mesilato de Imatinib / Enfermedad Injerto contra Huésped / Antineoplásicos Límite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2015 Tipo del documento: Article